Patents by Inventor Jason Cameron
Jason Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8748380Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.Type: GrantFiled: November 1, 2010Date of Patent: June 10, 2014Assignee: Novozymes Biopharma DK A/SInventors: Andrew Plumridge, Darrell Sleep, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
-
Publication number: 20140128326Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.Type: ApplicationFiled: November 8, 2013Publication date: May 8, 2014Applicants: Novozymes Biopharma DK A/S, University of OSLO, Novozymes Biopharma UK Limited, Novozymes A/SInventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
-
Patent number: 8707515Abstract: A strain relief device for securing three radially arrayed flat cables coming into a closure includes a body having three armatures extending radially. Each armature includes at least two cantilevered segments extending from the at least one armature in opposing directions. At least one cable may be received in a receiving area partially defined by the armature and the cantilevered segment. Compressive force acting on the strain relief device secures the cables in the receiving area relative to the strain relief device.Type: GrantFiled: May 24, 2012Date of Patent: April 29, 2014Assignee: Corning Cable SystemsInventors: Jason Cameron Payne, Karyne Poissant Prevratil, Howard Clark Schwartz
-
Publication number: 20140044400Abstract: A fiber management frame for a fiber optic closure having a removable tray holder configured to mount a fiber optic tray offset from a fiber management interface. The tray holder has optical fibers mounted thereon and can be mounted and/or removed from the fiber management interface without interfering with optical fibers mounted on the fiber management interface. The fiber management interface defines a first slack storage area for a first group of optical fibers. The removable tray holder defines a second slack storage area for a second group of optical fibers offset from the fiber management interface. The fiber optic tray can be mounted to or removed from the fiber management interface without interfering with the first group of optical fibers.Type: ApplicationFiled: May 30, 2013Publication date: February 13, 2014Applicant: Corning Cable Systems LLCInventors: Salvador Anguiano, Jason Cameron Payne, Karyne Poissant Prevratil, John Joseph Stillwell
-
Patent number: 8607837Abstract: An apparatus for stripping metal from a cathode plate, the apparatus comprising stripping means adapted for positioning between the metal and the cathode plate in order to separate the metal from the cathode plate, and wherein movement of the stripping means is achieved through movement of a robotic arm.Type: GrantFiled: February 5, 2010Date of Patent: December 17, 2013Assignee: Xstrata Technology Pty Ltd.Inventors: Anthony John Ruddell, Per Ola Eriksson, Jason Cameron Schulte, Gavin Jeffery Tang Sue Yek
-
Publication number: 20130225496Abstract: The invention relates to variants of albumin. The invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of preparing the variants and to methods of using the variants.Type: ApplicationFiled: November 1, 2011Publication date: August 29, 2013Applicant: Novozymes Biopharma DK A/SInventors: Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
-
Publication number: 20130028930Abstract: The application discloses albumin derivatives comprising or consisting of domain III and at least one further domain wherein the derivative or variant is not a naturally occurring albumin derivative or variant. The derivatives may be used in conjugates and fusion polypeptides.Type: ApplicationFiled: April 8, 2011Publication date: January 31, 2013Applicant: NOVOZYMES BIOPHARMA DK A/SInventors: Andrew Plumridge, Darrell Sleep, Inger Sandlie, Jan Terje Andersen, Jason Cameron, Leslie Evans, Steven Athwal, Elizabeth Allan, Esben Peter Friis
-
Publication number: 20120322739Abstract: The invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The invention also relates to fusion polypeptides and conjugates comprising said variant albumin.Type: ApplicationFiled: May 4, 2012Publication date: December 20, 2012Applicants: Novozymes Biopharma UK Limited, Novozymes Biopharma DK A/S, Novozymes A/S, University of OsloInventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Delahay
-
Publication number: 20120297574Abstract: A strain relief device for securing three radially arrayed flat cables coming into a closure includes a body having three armatures extending radially. Each armature includes at least two cantilevered segments extending from the at least one armature in opposing directions. At least one cable may be received in a receiving area partially defined by the armature and the cantilevered segment. Compressive force acting on the strain relief device secures the cables in the receiving area relative to the strain relief device.Type: ApplicationFiled: May 24, 2012Publication date: November 29, 2012Inventors: Jason Cameron Payne, Karyne Poissant Prevratil, Howard Clark Schwartz
-
Publication number: 20120220530Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.Type: ApplicationFiled: November 1, 2010Publication date: August 30, 2012Applicant: Novozymes Biopharma DK A/SInventors: Andrew Plumridge, Darrell Sleep, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
-
Publication number: 20120149873Abstract: An improved method for purifying albumin, a variant or fragment thereof, a fusion protein comprising albumin, a variant or fragment thereof, or a conjugate comprising albumin, a variant or fragment thereof is disclosed.Type: ApplicationFiled: May 7, 2010Publication date: June 14, 2012Applicant: NOVOZYMES BIOPHARMA DK A/SInventors: Lee Edward Blackwell, Jason Cameron, Phillip Harvey Morton
-
Publication number: 20120106912Abstract: A fiber optic module having a module housing and a module sub-assembly. The module housing defines at least an interior space, at least one adapter aperture and at least one input aperture. The module sub-assembly defines at least one fiber optic cable, for example, passing through the at least one input aperture, at least one multi-fiber connector on an end of the fiber optic cable, and at least one single fiber connector on an opposite end of the fiber optic cable, the multi-fiber connector being in optical communication with the at least one single fiber connector, the multi-fiber connector capable of flexing on the at least one fiber optic cable relative to the module housing.Type: ApplicationFiled: October 26, 2011Publication date: May 3, 2012Inventors: Daniel Scott McGranahan, Kenneth Charles Simonson, Jason Cameron Payne
-
Publication number: 20120037319Abstract: An apparatus for stripping metal from a cathode plate, the apparatus comprising stripping means adapted for positioning between the metal and the cathode plate in order to separate the metal from the cathode plate, and wherein movement of the stripping means is achieved through movement of a robotic arm.Type: ApplicationFiled: February 5, 2010Publication date: February 16, 2012Applicant: Xstrata Technology Pty Ltd.Inventors: Anthony John Ruddell, Per Ola Eriksson, Jason Cameron Schulte, Gavin Jeffery Tang Sue Yek
-
Publication number: 20110313133Abstract: Based on the three-dimensional structure of albumin, the inventors have designed variant polypeptides (muteins) which have one or more cysteine residues with a free thiol group (hereinafter referred to as “thio-albumin”). The variant polypeptide may be conjugated through the sulphur atom of the cysteine residue to a conjugation partner such as a bioactive compound.Type: ApplicationFiled: February 11, 2010Publication date: December 22, 2011Applicants: Novozymes A/S, Novozymes BioPharma DK A/SInventors: Christopher John Arthur Finnis, Joanna Mary Hay, Esben Peter Friis, Jason Cameron, Darrell Sleep
-
Publication number: 20110301329Abstract: A process is provided for the preparation of a highly pure albumin solution the process comprising subjecting albumin (preferably expressed and secreted by transformed yeast) to a series of chromatographic steps. Preferably, the process comprises the steps of positive mode cation exchange chromatography, positive mode anion exchange chromatography, positive mode affinity chromatography, negative mode affinity chromatography (preferably using immobilised aminophenylboronic acid), negative mode cation exchange chromatography, and negative or positive mode anion exchange chromatography. A process for reducing the level of nickel in an albumin solution is also disclosed, as is a recombinant albumin coding sequence comprising two or more in-frame translation stop codons.Type: ApplicationFiled: July 1, 2011Publication date: December 8, 2011Applicant: Novozymes Biopharma DK A/SInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Publication number: 20110294988Abstract: A process for purifying a transferrin solution and the product of the purification process. A process for producing transferrin and the product of the production process. Use of the transferrin in cell culture, as a pharmaceutical ingredient, as a pharmaceutical product and in a cell culture medium.Type: ApplicationFiled: February 5, 2010Publication date: December 1, 2011Applicant: Novozymes Bio Pharma DK A/SInventors: Lee Edward Blackwell, Jason Cameron, Phillip Harvey Morton
-
Patent number: 7993877Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.Type: GrantFiled: September 9, 2008Date of Patent: August 9, 2011Assignee: Novozymes Biopharma DK A/SInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Publication number: 20090171070Abstract: A process is provided for the preparation of a highly pure recombinant albumin solution having a nickel ion content of less than 100 ng per gram of albumin. The process comprises subjecting a recombinant albumin to a series of chromatography, concentration, and diafiltration steps.Type: ApplicationFiled: September 9, 2008Publication date: July 2, 2009Applicant: NOVOZYMES BIOPHARMA UK LIMITEDInventors: Hendrik Van Urk, David John Mead, Philip Harvey Morton, Andrew John Cartwright, Jason Cameron, David James Ballance, Michel Gaston Joseph Grandgeorge, Stephen Berezenko, John Rodney Woodrow, Darrell Sleep, Jean-Luc Bernard Veron
-
Publication number: 20070082004Abstract: The present invention provides a method for removing a proteinaceous component from a liquid-phase surfactant preparation comprising (a) providing a liquid-phase surfactant preparation containing a proteinaceous component; (b) adding a complexing agent to the preparation of step (a) and allowing the complexing agent to form a complex with the surfactant; (c) simultaneously with step (b), or subsequently, adding a miscible precipitating agent to the preparation of step (a) or the product of step (b), io respectively, to form a liquid-phase reaction mixture and allowing the miscible precipitating agent to precipitate the proteinaceous component within the liquid-phase reaction mixture; and (d) separating the said complex from the precipitated proteinaceous component in the product of step (c) to provide a purified liquid-phase surfactant preparation; wherein the complex remains in solution within the liquid-phase reaction mixture, and wherein step (d) retains the complex in the liquid phase.Type: ApplicationFiled: May 7, 2004Publication date: April 12, 2007Applicant: Delta Biotechnology LimitedInventors: Philip Morton, Jason Cameron